WuXi AppTec’s Post

We recently broke ground in #Singapore!   Projected to start operations in 2027, our new Singapore site will offer API manufacturing for small molecules, oligonucleotides, peptides, and complex chemical conjugates, enhancing WuXi AppTec’s #CRDMO enabling platform. We look forward to continuing to support our customers worldwide in bringing more innovative treatments to patients in need.

Our mission goes beyond advancing healthcare innovations; we are equally dedicated to protecting the planet we all share🌱  Recently, our San Diego office proudly participated in Coastal Cleanup Day, organized by the nonprofit organization I Love A Clean San Diego, joining thousands of volunteers to clean the local beaches and support the global effort to safeguard our oceans. Together, we walked along the beautiful San Diego coastline, covering 5 kilometers (3.1 miles) and collecting 121 kilograms (267 pounds) of marine debris. As one of the largest corporate teams involved, we’re proud to have played a part in reducing plastic waste to preserve our environment for future generations.   This effort is a reflection of WuXi AppTec’s broader commitment to supporting the communities where we operate. Across our 32 global sites, our teams are driving positive change – not just through breakthrough therapies, but through meaningful contributions to local economies and environmental sustainability as well. #CoastalCleanup #Sustainability 

Our commitment to social responsibility extends far beyond the lab. In honor of #InternationalDayofCharity, we are  proud to highlight our St. Paul site's 25th blood drive. Supported by our generous colleagues, the annual tradition collected 23 units of donated blood—each unit potentially saving up to 3 lives. Since 2019, our St. Paul team has collected 479 units, demonstrating our commitment to making a meaningful impact. This program is just one example of how our global workforce contributes to a healthier world, reinforcing our mission to enable life-saving #innovations. #LifeSciences #healthcare 

We are pleased to announce that WuXi AppTec has maintained its AA #MSCI ESG rating for the fourth consecutive year! The rating reflects WuXi AppTec’s commitment to incorporating environmental and social responsibilities into the company’s business strategies and operations. As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec’s outstanding #ESG performance has been widely acknowledged by major global ESG rating agencies, including CDP, EcoVadis, S&P and Sustainalytics. https://lnkd.in/gT4Cwq7F

Take a look at our pioneering #CRDMO model.   Through the platform, we enable scientific innovations, develop distinct industry insights, quickly adapt to opportunities in new molecules as they rise, and continue to drive solid business growth. See how we’re accelerating the delivery of life-saving therapies and benefitting patients across the globe ⬇️   #Innovation #LifeSaving 

Our #H1Report performance demonstrates that our unique integrated #CRDMO business model can effectively meet the growing demand of customers worldwide.    We’re committed to continuously enhancing our capabilities and capacity to bring groundbreaking therapies to patients around the world.   See how we’re “doing the right thing and doing it right”: https://lnkd.in/ef-rsnzr

We are excited to announce that our new Munich site at the Life Science Center in Gräfelfing is now open, marking a key step forward in strengthening our CRDMO platform.   Located in the heart of the Munich biotech cluster, the new facility expands our structure-based drug discovery and lab testing capabilities – housing them under one roof. This will enhance our services to better support our customers in Europe and beyond.   Strong synergy across our sites enables innovation and collaboration, helping deliver more groundbreaking therapies to patients who need it most.   #Innovation #LifeSciences

We're delighted to announce that WuXi AppTec has been included in the #FTSE4Good Index Series for the second consecutive year!    This recognition demonstrates our exceptional performance in environmental, social, and governance (#ESG) practices driven by our commitment to advancing #sustainability and enabling #innovation for a healthier world. An independent assessment by FTSE Russell, An LSEG Business, a global index and data provider, scored WuXi AppTec above global industry standards.   Through our unique CRDMO and CTDMO business models, we continue to support customers’ needs by developing and delivering innovative new therapies to patients worldwide, working together towards a better and more sustainable future.